Heiq Share Discussion Threads

[zen12] 31/10/2023 10:49

At least Carlo is a significant shareholder and has the money where his mouth is...this cannot be said for majority of BoD on the markets. Happy to use shareholder monies

[catabrit] 31/10/2023 10:16

Fully expecting to see a director buy RNS tomorrow by Carlo for a significant sum.

[catabrit] 31/10/2023 08:40

I am happy to reevaluate the deal. I was wrong to buy as much as I did at 19p. But I am happy to own it at 9p even if it means I am stomaching a massive loss. In my isa as well which is annoying. The story has collapsed and this could take a long time to recover, if it ever does.

Carlo should be embarrassed that he has overseen such a disastrous loss of wealth for himself and other shareholders.

[terminator101] 31/10/2023 08:15

Well that went well huh.

[davemac3] 31/10/2023 08:12

First sale, 1 share, probably a signal

[davemac3] 31/10/2023 07:56

back trading today, tin hat time?

[catabrit] 30/10/2023 21:00

Results about what I expected. I need to dig into that claim and whether it is mentioned in the report. I did not see a note of it in the RNS. For me, the biggest here is that we all have major opportunity cost now. A lot of stuff is on sale and the environment has got much better for bargain hunters since April. So why own it? We need a damn good reason and I suspect that is what Carlo will want to address during the investor presentations. If this opens say fifty percent down, I will hold. If it opens about flat I think I would be very tempted to sell at least half.

[jammytass] 30/10/2023 16:27

they will not be around long enough to claim any with this very poor bod

[hedgehog 100] 30/10/2023 15:37

Looking on the positive side, at least HEIQ now has plenty of tax losses to potentially use later ...

[hedgehog 100] 30/10/2023 13:16

30/10/2023 07:00 UK Regulatory (RNS & others) HeiQ PLC Results for year ended 31 December 2022 LSE:HEIQ Heiq Plc

" ... Financial Overview:

-- Revenue reduced 14.8% to US$47.2 million (FY 2021 restated: US$55.4 million*)
-- Gross profit margin down 17.3% to 28.5% (FY 2021 restated: 45.8%*)
-- Adjusted EBITDA decreased to US-$12.2 million (FY 2021 restated: US$4.5 million*)
-- Operating loss of US-$29.2 million (FY 2021 restated: US$-1.4 million*)
-- Loss after taxation of US$-29.8 million (FY 2021 restated: US$-1.4 million*)
-- Cash at year-end of $8.5m with net debt (including lease liabilities) of US$3.7 million ..."




30/10/2023 07:01 UK Regulatory (RNS & others) HeiQ PLC Interim Results LSE:HEIQ Heiq Plc

"Half year results for the period ended 30 June 2023

HeiQ Plc (LSE:HEIQ), a leading company in materials innovation and hygiene technologies, announces its interim results for the period ending 30 June 2023 ("H1 2023").

These results are published concurrently with the Company's final results for the full year ended 31 December 2022 ("FY 22").

Restoration of Trading:

As detailed in the FY 22 results, upon uploading the Annual Report 2022 to the National Storage Mechanism, expected to be completed today, the Company will make an immediate request to the FCA for the Company's Ordinary Shares to be restored to trading on the Main Market of the London Stock Exchange as soon as practicable thereafter. A further announcement will be made confirming the exact time and date of resumption of trading.

Financial Overview:

-- Revenue reduced by 26% to US$20.5 million (H1 2022 restated*: US$27.6 million)
-- Gross profit margin of 40.9% (H1 2022 restated*: 41.5% in H1 2022)
-- Adjusted EBITDA of US-$3.6 million (H1 2022 restated*: US$0.7 million)
-- Operating loss of US-$6.0 million (H1 2022 restated*: US-$1.6 million)
-- Loss after taxation of US$-6.5 million (H1 2022 restated*: profit of US-$1.9 million)
-- Cash balance as at 30 June 2023 of US$7.3 million

Operational Overview:

Trading conditions for the markets of our commercialized product range continued to be challenging during H1 2023 and, as highlighted in detail in our Full Year results for the 12 months to 31 December 2022, the Company took decisive steps to reduce its cost base and reorganize the business to maintain its innovation and differentiation capabilities during the period under review. With costs reduced and operations adapted in light of the challenging headwinds our entire industry is facing, the Company expects H2 2023 trading to stabilize.

Post Period:

The Company is closely monitoring the market and is ready to take further cost reduction action, should it need to. We continue to add value to our high potential key innovation initiatives through focused investment, to position ourselves for when the macro-economic difficulties abate.

While the Board considers the Company has adequate resources, it is in discussions with financial institutions to replace the currently uncommitted credit facilities by committed, long-term facilities.

Equity analyst and shareholder presentations:

Following the resumption of trading in its ordinary shares the Company will announce registration details for two live presentations. These presentations will cover today's results and will be held separately for both equity analysts and investors. ..."

[hibberts] 30/10/2023 07:48

The results were never going to be good.The fact that the shares commenced trading and the management are having an investors presentation gives me some hope.
I really thought it was game over for shareholders.

[pugugly] 30/10/2023 07:29

Results probably worse than many expected.

[davemac3] 27/10/2023 22:16

they are taking the pi$$

[catabrit] 27/10/2023 22:03

I agree DaveMac. The whole thing is rather amateurish and the market is full of bargains at the minute. I hate people that over promise and under deliver and from listing to this week, that is basically what they have done.

[pugugly] 27/10/2023 17:01

Market now closed - No announcement yet 7 hours left!!!!!!
"23 October 2023

HeiQ Plc

("HeiQ" or "the Company")

Notice of Results and Audit Update

HeiQ (LSE:HEIQ), a leading company in materials innovation and hygiene technologies, announces that its audited accounts for the year ended 31 December 2022 ("2022 Accounts") will be published this week alongside its results for the six months ended 30 June 2023 ("H1 2023").

[catabrit] 27/10/2023 13:43

I suppose they want shareholders to have the weekend to look through the accounts before determining whether they should vote with their feet after the lengthy delay and shambolic IR.

[pugugly] 27/10/2023 08:50

Looks as thought accounts being left until after market closes. That is if the rns is to be believed.
However can you trust the Swiss?

[catabrit] 26/10/2023 19:08

Some of the revenue was but they are still generating fifty million dollars per annum. That is a lot more than Renewcell I believe.

[pugugly] 26/10/2023 18:43

Catabrit:- from the rns - Revenue wrongly recognised so not sure if y our revenue figure above is correct.
Will have to wait for audited accounts.

"it is necessary to defer revenues (and corresponding profits) that were originally recognized in H1 2022 and H2 2022 from certain milestone partnership agreements. Following our review of the contractual arrangements it is now deemed appropriate to recognize such revenues over a longer time period to coincide with specific exclusivity rights being granted by HeiQ to the partners. Consequently, revenue of US$4.0 million that was previously recognized during FY 2022 has been deferred over a period of 4 years with initial revenues being recognized in H2 2022. This means the Company now expects revenues for FY 2022, alongside gross profits and loss from operations, to be below previous market guidance. "

[catabrit] 26/10/2023 16:28

The Renewcell comparison is wrong because circulose only comprises one part HEIQ. HEIQ is more diversified and also has $50m of annual revenue.